Supplementary Data from The First-in-Human Study of the Hydrogen Sulfate (Hyd-Sulfate) Capsule of the MEK1/2 Inhibitor AZD6244 (ARRY-142886): A Phase I Open-Label Multicenter Trial in Patients with Advanced Cancer

Authors :: Carla M.L. van Herpen
Paul D. Smith
Sarah M.A. George
Clive Morris
Mireille V. Cantarini
Kathryn H. Brown
Karl D. Lewis
S. Gail Eckhardt
Johanna N.H. Timmer-Bonte
Ingrid M.E. Desar
Stan B. Kaye
Debashis Sarker
Roshan Agarwal
Henk M.W. Verheul
D. Ross Camidge
Udai Banerji
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Supplementary Data from The First-in-Human Study of the Hydrogen Sulfate (Hyd-Sulfate) Capsule of the MEK1/2 Inhibitor AZD6244 (ARRY-142886): A Phase I Open-Label Multicenter Trial in Patients with Advanced Cancer

Full Text Access

Tools